Impaired cell fate through gain-of-function mutations in a chromatin reader

被引:100
|
作者
Wan, Liling [1 ,16 ]
Chong, Shasha [2 ,3 ]
Xuan, Fan [4 ]
Liang, Angela [1 ]
Cui, Xiaodong [5 ,6 ]
Gates, Leah [1 ]
Carroll, Thomas S. [7 ]
Li, Yuanyuan [8 ]
Feng, Lijuan [1 ]
Chen, Guochao [8 ]
Wang, Shu-Ping [9 ,10 ]
Ortiz, Michael V. [11 ]
Daley, Sara K. [12 ]
Wang, Xiaolu [4 ]
Xuan, Hongwen [4 ]
Kentsis, Alex [11 ,13 ]
Muir, Tom W. [12 ]
Roeder, Robert G. [9 ]
Li, Haitao [8 ]
Li, Wei [5 ,6 ,14 ]
Tjian, Robert [2 ,3 ,15 ]
Wen, Hong [4 ]
Allis, C. David [1 ]
机构
[1] Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10021 USA
[2] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA
[4] Van Andel Inst, Ctr Epigenet, Grand Rapids, MI 49546 USA
[5] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
[6] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[7] Rockefeller Univ, Bioinformat Core, 1230 York Ave, New York, NY 10021 USA
[8] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing Adv Innovat Ctr Struct Biol,MOE Key Lab P, Beijing, Peoples R China
[9] Rockefeller Univ, Lab Biochem & Mol Biol, 1230 York Ave, New York, NY 10021 USA
[10] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan
[11] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA
[12] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA
[13] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA
[14] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA
[15] Univ Calif Berkeley, CIRM Ctr Excellence, Berkeley, CA 94720 USA
[16] Univ Penn, Dept Canc Biol, Perelman Sch Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
TRANSCRIPTION; ELONGATION; COMPLEX; ENL; TEFB; AFF4;
D O I
10.1038/s41586-019-1842-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Modifications of histone proteins have essential roles in normal development and human disease. Recognition of modified histones by 'reader' proteins is a key mechanism that mediates the function of histone modifications, but how the dysregulation of these readers might contribute to disease remains poorly understood. We previously identified the ENL protein as a reader of histone acetylation via its YEATS domain, linking it to the expression of cancer-driving genes in acute leukaemia1. Recurrent hotspot mutations have been found in the ENL YEATS domain in Wilms tumour2,3, the most common type of paediatric kidney cancer. Here we show, using human and mouse cells, that these mutations impair cell-fate regulation by conferring gain-of-function in chromatin recruitment and transcriptional control. ENL mutants induce gene-expression changes that favour a premalignant cell fate, and, in an assay for nephrogenesis using murine cells, result in undifferentiated structures resembling those observed in human Wilms tumour. Mechanistically, although bound to largely similar genomic loci as the wild-type protein, ENL mutants exhibit increased occupancy at a subset of targets, leading to a marked increase in the recruitment and activity of transcription elongation machinery that enforces active transcription from target loci. Furthermore, ectopically expressed ENL mutants exhibit greater self-association and form discrete and dynamic nuclear puncta that are characteristic of biomolecular hubs consisting of local high concentrations of regulatory factors. Such mutation-driven ENL self-association is functionally linked to enhanced chromatin occupancy and gene activation. Collectively, our findings show that hotspot mutations in a chromatinreader domain drive self-reinforced recruitment, derailing normal cell-fate control during development and leading to an oncogenic outcome.
引用
收藏
页码:121 / +
页数:18
相关论文
共 50 条
  • [31] Mutational Profiling of Ameloblastoma Identifies Common Gain-of-Function Mutations
    McClary, A. C.
    Sweeney, R. T.
    Biscocho, J.
    Meyers, B. R.
    Neahring, L.
    Kwei, K. A.
    Qu, K.
    Gong, X.
    Jones, C. D.
    Varma, S.
    Odegaard, J. I.
    Rubin, B.
    Ng, T.
    Troxell, M. L.
    Pelham, R. J.
    Zehnder, J. L.
    Beachy, P. A.
    Pollack, J. R.
    West, R. B.
    MODERN PATHOLOGY, 2014, 27 : 324A - 324A
  • [32] Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology
    Grice, Stuart J.
    Sleigh, James N.
    Motley, William W.
    Liu, Ji-Long
    Burgess, Robert W.
    Talbot, Kevin
    Cader, M. Zameel
    HUMAN MOLECULAR GENETICS, 2015, 24 (15) : 4397 - 4406
  • [33] Using SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function Mutations
    Flanagan, Sarah E.
    Patch, Ann-Marie
    Ellard, Sian
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2010, 14 (04) : 533 - 537
  • [34] Gain-of-function β-catenin in the uterine mesenchyme leads to impaired implantation and decidualization
    Patterson, Amanda L.
    Pirochta, Jamieson
    Tufano, Stephanie Y.
    Teixeira, Jose M.
    JOURNAL OF ENDOCRINOLOGY, 2017, 233 (01) : 119 - 130
  • [35] Loss- and Gain-of-function Approach to Investigate Early Cell Fate Determinants in Preimplantation Mouse Embryos
    Lee, Jae H.
    Cho, Yong Il
    Choi, Sung S.
    Kim, Hae-Won
    Min, Churl K.
    Lee, Sang J.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (112):
  • [36] Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations
    Chen, Huaibin
    Huang, Zhifeng
    Dutta, Kaushik
    Blais, Steven
    Neubert, Thomas A.
    Li, Xiaokun
    Cowburn, David
    Traaseth, Nathaniel J.
    Mohammadi, Moosa
    CELL REPORTS, 2013, 4 (02): : 376 - 384
  • [37] Tetrameric and monomeric gain-of-function mutant p53 interacts with chromatin
    Annor, George Kwakye
    CANCER RESEARCH, 2022, 82 (04)
  • [38] A catalogue of somatic NRF2 gain-of-function mutations in cancer
    Kerins, Michael John
    Ooi, Aikseng
    SCIENTIFIC REPORTS, 2018, 8
  • [39] The human thyrotropin receptor is highly mutable: a review of gain-of-function mutations
    Farid, NR
    Kascur, V
    Balazs, C
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (01) : 25 - 30
  • [40] Gain-of-Function KCNH2 Mutations in Patients with Brugada Syndrome
    Wang, Qi
    Ohno, Seiko
    Ding, Wei-Guang
    Fukuyama, Megumi
    Miyamoto, Akashi
    Itoh, Hideki
    Makiyama, Takeru
    Wu, Jie
    Bai, Jiayu
    Hasegawa, Kanae
    Shinohara, Tetsuji
    Takahashi, Naohiko
    Shimizu, Akihiko
    Matsuura, Hiroshi
    Horie, Minoru
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2014, 25 (05) : 522 - 530